CSS
TSVT

Cubist Systematic Strategies’s 2seventy bio TSVT Stock Holding History

Cubist Systematic Strategies’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,106
Closed -$41.9K – 4314
2023
Q1 		$41.9K Buy
4,106
+3,694
+897% +$42.2K ﹤0.01% 3594
2022
Q4 		$3.86K Sell
412
-24,297
-98% -$343K ﹤0.01% 4098
2022
Q3 		$360K Buy
24,709
+23,662
+2,260% +$351K ﹤0.01% 3405
2022
Q2 		$14K Sell
1,047
-2,353
-69% -$32.1K ﹤0.01% 4246
2022
Q1 		$58K Buy
3,400
+1,324
+64% +$22.5K ﹤0.01% 3351
2021
Q4 		$53K Buy
+2,076
New +$64.7K ﹤0.01% 3309

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's TSVT Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of 2seventy bio (TSVT) in Q2 2023, closing a stake of 4,106 shares — an estimated $41.9K sold.

Cubist Systematic Strategies first reported a position in TSVT in Q4 2021 and held it in 6 quarters. The position peaked at $360K in Q3 2022. 149 funds tracked by Wall St. Rank hold TSVT as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining 2seventy bio position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 4,106 2seventy bio shares in Q2 2023, an estimated $41.9K.
  • Cubist Systematic Strategies first reported a position in 2seventy bio in Q4 2021 and held it in 6 quarters.
  • Cubist Systematic Strategies's 2seventy bio position peaked at $360K in Q3 2022.
  • 149 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.